Evaluation of training dose in male Sprague-Dawley rats trained to discriminate 4-methylmethcathinone.
Michael D. Berquist, Nathyn A Thompson, Lisa E Baker
Psychopharmacology November 2017 DOI: 10.1007/s00213-017-4716-4 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Drug discrimination study in rats Qualitative Peer reviewed |
|---|---|
| Sample size | 16 |
| Population | Male Sprague-Dawley rats |
| Interventions | 4-MMC d-amphetamine (+)-methamphetamine MDMA MDPV (-)-cocaine (+)-fenfluramine (+)-LSD |
| Dose | 1.0 mg/kg or 3.0 mg/kg 4-MMC |
| Keywords | 4-mmc 4-methylmethcathinone Bath salts Drug discrimination Mephedrone Synthetic cathinone |
| Key points | The interoceptive stimulus effects of 4-MMC varied little with training dose, but qualitative differences in substitutability of test drugs were observed between the 1.0 mg/kg and 3.0 mg/kg training groups. Cocaine, MDMA, and d-amphetamine fully substituted in the 1.0 mg/kg group at doses that did not decrease response rate, whereas doses engendering over 80% 4-MMC-lever selection in the 3.0 mg/kg group also produced rate-decreasing effects. |
Abstract
Although the synthetic cathinone 4-methylmethcathinone (4-MMC, mephedrone) has been a subject of intensive research investigation, the pharmacological mechanisms involved in its interoceptive stimulus effects have yet to be fully characterized. The present study employed drug discrimination methods in rats to compare the interoceptive stimulus properties of two different training doses of 4-MMC to other substances with similar pharmacological actions. Sixteen male Sprague-Dawley rats were trained to discriminate either 1.0 mg/kg (N = 8) or 3.0 mg/kg (N = 8) 4-MMC from saline. Substitution tests were conducted with drugs that increase extracellular monoamine levels (d-amphetamine, (+)-methamphetamine, 4-MMC, MDMA, MDPV, and (-)-cocaine), a serotonin releaser (+)-fenfluramine, and a serotonergic (5-HT2A) hallucinogen (+)-LSD. Stimulus control was established in fewer sessions in the subjects trained with 3.0 mg/kg compared to those trained with 1.0 mg/kg 4-MMC. Cocaine, MDMA, and d-amphetamine produced full substitution in the 1.0 mg/kg 4-MMC-trained rats at doses that did not decrease response rate. However, doses of test drugs that engendered > 80% 4-MMC-lever selection concurrently produced rate-decreasing effects in rats trained to discriminate 3.0 mg/kg 4-MMC. These findings further characterize the interoceptive stimulus effects of 4-MMC and indicate that these effects vary little with training dose; however, qualitative differences in substitutability of test drugs were observed between training groups. This study expands existing knowledge regarding the psychopharmacology of 4-MMC and the potential neurochemical substrates contributing to its subjective effects.
Citations in the library
Cited by 5
- Re-evaluation of the discriminative stimulus effects of lysergic acid diethylamide with male and female Sprague-Dawley rats Behavioural Pharmacology December 1, 2020
- Methylenedioxymethamphetamine-like discriminative stimulus effects of seven cathinones in rats Behavioural Pharmacology June 1, 2020
- Addressing the Current Knowledge and Gaps in Research SurroundingLysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in RodentModels Current Topics in Medicinal Chemistry July 6, 2023
- Locomotor sensitization in male Sprague-Dawley rats following repeated concurrent treatment with 4-methylmethcathinone and 3,4-methylenedioxymethamphetamine Behavioural Pharmacology October 1, 2019
- Evaluating the abuse potential of psychedelic drugs as part of the safety pharmacology assessment for medical use in humans. Neuropharmacology November 2018
Cites 5
- Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats British Journal of Pharmacology May 26, 2011
- Atypical binding at dopamine and serotonin transporters contribute to the discriminative stimulus effects of mephedrone. Neuropharmacology June 2017
- Bath salts and synthetic cathinones: an emerging designer drug phenomenon. Life Sciences February 27, 2014
- The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue. Neuropsychopharmacology December 14, 2011
- 4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse. Journal of Pharmacology and Experimental Therapeutics November 2011